Cervical Arthroplasty "Fixed Core" Versus "Movable Core": Clinical and Radiological Impact in the Medium Term

NCT ID: NCT02924506

Last Updated: 2019-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-19

Study Completion Date

2018-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nowadays, there is no clinical and radiological study comparing two different types of mobile implants in patients requiring surgical treatment for symptomatic cervical disc disease. Thus, the choice of the ideal implant remains uncertain.

The goal of this work is to compare the impact of two types of mobile implants in height drives, solicitation facets, positioning and collection of prostheses within the intervertebral spaces.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neck Pain Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fixed Core

Cervical arthroplasty with fixed core prothesis

Group Type OTHER

ProDisc-C prothesis

Intervention Type DEVICE

ProDisc-C prothesis, Vivo Depuy Synthes (company)

Movable Core

Cervical arthroplasty with movable core prothesis

Group Type OTHER

Mobi-C prothesis

Intervention Type DEVICE

Mobi-C Prothesis, LDR Medical (company)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobi-C prothesis

Mobi-C Prothesis, LDR Medical (company)

Intervention Type DEVICE

ProDisc-C prothesis

ProDisc-C prothesis, Vivo Depuy Synthes (company)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years
* Symptomatic cervical disc degenerative pathologies to 1 or more contiguous or non-contiguous levels C3-4 to C6-7.
* Symptoms including: Cervicobrachial neuralgia and / or Loss of root muscle strength and / or Sensory impairment and paresthesia and / or Cervical myelopathy table
* Concordant diagnosis confirmed by CT (Computerized Tomography scanner) and MRI (Magnetic Resonance Imaging) of the cervical spine
* NPDS (Neck Pain and Disability Scale) \> 30
* Failure to respond to conservative medical treatment for 6 weeks or worsening symptoms despite conservative treatment
* Physical and mental fitness to ensure compliance with the protocol
* Signed informed consent

Exclusion Criteria

* Unstable cervical spine injuries requiring fusion C1 to C7 for whatever the etiology, proven on dynamic views of the cervical spine
* Paget's disease, osteomalacia, other metabolic bone diseases
* Chronic corticosteroid use
* Active tumor pathology
* Segmental angulation \< -11 ° or \> 11 ° at the respective segment or adjacent segments on static images of the cervical spine
* Known allergy to Chromium, Cobalt, Mobdylene (chemical element), Polyethylene, or Titanium
* History of surgery in the previous 30 days before inclusion
* History of mental illness or disability involving a "safeguard procedure justice of the person"
* Contraindications to non steroidal anti inflammatory
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Régional d'Orléans

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thierry DUFOUR, Ph

Role: PRINCIPAL_INVESTIGATOR

CHR d'Orleans

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHR d'ORLEANS

Orléans, , France

Site Status

Hôpital Bretonneau, CHU DE TOURS

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHRO-2014-04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fusion Status After ACDF
NCT05986006 UNKNOWN NA